Patient Advocacy: Insurance Denial and Step Therapy
MMIHardAnswer the question
Patient Advocacy: Insurance Denial and Step Therapy
You are a third-year medical student on an internal medicine rotation. A 45-year-old patient with newly diagnosed multiple sclerosis has been prescribed a disease-modifying therapy by the attending neurologist. The insurance company has denied the claim, requiring the patient to first try and fail two older, less effective agents -- a process called step therapy. The patient is tearful and afraid her condition will worsen during the months it takes to complete step therapy. Your attending is busy. What steps can you take, and what have you learned about the tension between clinical best practice and insurance cost management?
What is step therapy, and what is the clinical argument for and against it in a condition like multiple sclerosis?
What resources exist within a hospital system to help patients navigate insurance denials?
How do you support a patient emotionally when the healthcare system is failing them?
Speak it out loud and we'll type it for you (free), or type your own notes — then mark yourself below.
- SPIKES for breaking bad news: Setting, Perception, Invitation, Knowledge, Empathy, Strategy.
- Listen → empathise → check understanding → agree a plan together. Calm voice, no jargon.
What strong answers doReveal the benchmark
Hidden so they don't bias your answer. Score yourself first, then reveal them to compare.
- As a student your direct authority is limited, but your responsibility is not zero. Immediately involve the appropriate people: notify your attending of the denial, contact the hospital's patient financial counselor or case manager (they have experience with insurance appeals), and ask the drug manufacturer's patient support program about free medication bridges or prior authorization support. You do not solve this alone, but you activate the right network.
- Step therapy is used by insurers to reduce costs by requiring patients to try cheaper alternatives before approving more expensive treatments. The clinical argument against it in MS is that DMT efficacy is strongly associated with early, aggressive treatment -- delays can allow irreversible neurological damage. Knowing this allows you to articulate the clinical urgency so the attending can frame the appeal around patient harm risk.
- Emotional support while the system fails the patient: acknowledge the injustice directly. 'I understand this feels unfair, and it is unfair' is a powerful thing for a healthcare provider to say, because it validates the patient's experience without offering false hope. Then pivot to action: 'Here is what we are doing right now.' Giving a concrete plan reduces the helplessness.
Mark yourself
Score each skill against the rubric, then add a line of evidence. Scale:
Patient Advocacy
0/3Identifies concrete steps to support the patient within the student role
Communication
0/3Demonstrates how to acknowledge systemic failure while maintaining therapeutic presence
Health Policy Literacy
0/3Understands step therapy and its clinical implications
Teamwork
0/3Activates the appropriate hospital network rather than acting alone
Reflect & score
More free questions
- Role Play: Disclosing a Medical Error to a PatientRole Play & Communication
- Motivation: Why Medicine and Not Another Health ProfessionMotivation
- Motivation: MD Versus DO and the Osteopathic PathwayMotivation
- AAMC Core Competency: Capacity for Improvement — Learning from a Failed GradeMotivation